Order Article Reprints

Carbone D, Pecoraro C, Panzeca G, Xu G, Roeten MSF, Cascioferro S, Giovannetti E, Diana P, Parrino B. 1,3,4-Oxadiazole and 1,3,4-Thiadiazole Nortopsentin Derivatives against Pancreatic Ductal Adenocarcinoma: Synthesis, Cytotoxic Activity, and Inhibition of CDK1. Marine Drugs. 2023; 21(7):412. https://doi.org/10.3390/md21070412

Carbone, Daniela, Camilla Pecoraro, Giovanna Panzeca, Geng Xu, Margot S. F. Roeten, Stella Cascioferro, Elisa Giovannetti, Patrizia Diana, and Barbara Parrino. 2023. "1,3,4-Oxadiazole and 1,3,4-Thiadiazole Nortopsentin Derivatives against Pancreatic Ductal Adenocarcinoma: Synthesis, Cytotoxic Activity, and Inhibition of CDK1" Marine Drugs 21, no. 7: 412. https://doi.org/10.3390/md21070412

Carbone, D., Pecoraro, C., Panzeca, G., Xu, G., Roeten, M. S. F., Cascioferro, S., Giovannetti, E., Diana, P., & Parrino, B. (2023). 1,3,4-Oxadiazole and 1,3,4-Thiadiazole Nortopsentin Derivatives against Pancreatic Ductal Adenocarcinoma: Synthesis, Cytotoxic Activity, and Inhibition of CDK1. Marine Drugs, 21(7), 412. https://doi.org/10.3390/md21070412